Dystroglycanopathies are a group of clinically and genetically heterogeneous muscular dystrophies caused by mutations that lead to a defect in α-dystroglycan (α-DG) [1]. The gene discussed is DAG1; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.